Oslo, Norway (26 March 21)
As of 25 March 2021 NattoPharma ASA has terminated its market making contract with Norne Securities AS. The last day of participation will be 25 May 2021.
For more information, please contact:
Robert Schrama, CFO
This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.